# Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/patient-burden-of-moderate-to-severe-atopic-dermatitis-ad-insights-from-a-phase/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eric L. Simpson,Thomas Bieber,Laurent Eckert,Richard Wu,Marius Ardeleanu,Neil M.H. Graham,Gianluca Pirozzi,Vera Mastey |
| Citations | 305 |
| DOI | 10.1016/j.jaad.2015.10.043 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2276335262 |
| PMID | 26777100 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Thomas Bieber](https://scholariq.org/researchers/thomas-bieber/)
- [Marius Ardeleanu](https://scholariq.org/researchers/marius-ardeleanu/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.